首页> 外国专利> use, in the modulation of cholinergic and / or serotonergic and / or gabaergic systems of vertebrates, of a standardized crude plant extractor, pharmaceutical composition for the treatment of disorders associated with cholinergic and / or serotonergic and / or gabaergic system dysfunction, and production of medicament for the modulation of cholinergic and / or serotonergic and / or gabaergic systems of vertebrates

use, in the modulation of cholinergic and / or serotonergic and / or gabaergic systems of vertebrates, of a standardized crude plant extractor, pharmaceutical composition for the treatment of disorders associated with cholinergic and / or serotonergic and / or gabaergic system dysfunction, and production of medicament for the modulation of cholinergic and / or serotonergic and / or gabaergic systems of vertebrates

机译：用于调节脊椎动物的胆碱能和/或血清素能和/或gaberergy系统的标准粗植物提取物，用于治疗与胆碱能和/或血清素能和/或gaberergy系统功能障碍相关的疾病的药物组合物，用于调节脊椎动物胆碱能和/或血清素能和/或gaberergic系统的药物

页面导航

摘要
著录项
相似文献

摘要

Use, in the modulation of cholinergic or serotonergic and / or gabaergic systems of vertebrates, of a standardized crude plant extract, Pharmaceutical composition for the treatment of disorders associated with cholinergic myocardial serotonergic and / or gabaergic system disorders, Drug production process for the modulation of cholinergic and / or serotonergic and / or gabaergic systems of vertebrates. The present invention provides the use of molecules for the modulation of cholinergic and / or serotonergic and / or gabaergic systems, and pharmaceutical compositions comprising standardized crude plant extracts are disclosed. -OH-erytravine, erytravine, erythrartine, their pharmaceutically acceptable isomers, salts, derivatives or solvates thereof, or combinations thereof, optionally containing other erythritic derivatives, for the treatment of anxiety disorders; Processes for obtaining said pharmaceutical compositions are also disclosed.

机译：用于调节脊椎动物的胆碱能或血清素能和/或gabaergic系统的标准粗制植物提取物，用于治疗与胆碱能心肌血清素能和/或gabaergic系统疾病有关的疾病的药物组合物，调节脊椎动物的胆碱能系统和/或血清素能系统和/或伽巴能系统。本发明提供了分子用于调节胆碱能和/或血清素能和/或甘草能系统的用途，并且公开了包含标准化的粗植物提取物的药物组合物。 -OH-赤藓红，赤藓红，赤藓碱，它们的药学上可接受的异构体，盐，衍生物或溶剂化物，或它们的组合，任选地包含其他赤藓衍生物，用于治疗焦虑症;还公开了获得所述药物组合物的方法。

著录项

公开/公告号BRPI0504517A

专利类型
公开/公告日2007-09-25

原文格式PDF
申请/专利权人 UNIVERSIDADE ESTADUAL PAULISTA JULIO DE MESQUITA FILHO;
展开▼

申请/专利号BR2005PI04517
发明设计人 OTAVIO APARECIDO FLAUSINO JUNIOR;RICARDO LUIS NUNES DE SOUZA;VANDERLAN DA SILVA BOLZANI;
展开▼

申请日2005-10-20
分类号A61K36/48;A61K31/439;A61P25;
国家 BR
入库时间 2022-08-21 20:59:25

相似文献

专利
外文文献
中文文献